Mounjaro®
Starting from £179.99/mo
Start journey Learn moreFeeling unusually cold while taking semaglutide is something a number of people on Wegovy notice, particularly in the earlier weeks of treatment. It is not listed as a common side effect in the licensed product information, but it has a plausible physiological explanation rooted in how the medicine changes the way your body uses energy. This page looks at what the evidence actually says, what is likely harmless, and when a cold feeling deserves closer attention from a clinician.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
There is a widely held belief that feeling cold on semaglutide means the medicine is somehow suppressing your metabolism or making your thyroid underactive. That idea circulates on forums, and it is understandable why people reach for it. But it does not match how semaglutide actually works. Semaglutide is a GLP-1 receptor agonist: it acts on appetite-signalling pathways in the brain, slows gastric emptying, and reduces how much you feel like eating. It does not directly act on thyroid hormone output or core temperature regulation. Feeling cold is real for many people; the explanation just tends to be simpler than a broken metabolism.
If you want a fuller grounding in how semaglutide works in the body, the semaglutide overview on this site covers the mechanism in plain terms. The NHS medicines page for semaglutide lists the side effects that appear in the licensed product information, and a persistent cold feeling is not among the commonly reported ones.
When semaglutide reduces appetite significantly, calorie intake often drops quite sharply, especially in the first few weeks. Your body generates heat as a by-product of metabolising food; eat considerably less, and that heat production falls too. For some people this shows up as feeling chilly, particularly in the hands and feet, in a way that feels new. It is broadly the same phenomenon that people following a very low-calorie diet sometimes experience, and it tends to become less noticeable as eating habits stabilise and the body adjusts.
Early weight loss also plays a role. Fat tissue provides insulation; as adipose mass starts to reduce, some people find they feel draughts and cold rooms more than they used to. This is not unique to semaglutide — it is a well-documented feature of weight loss generally. There is a separate question of whether semaglutide specifically drives the cold sensation beyond what you would expect from calorie reduction alone, and the honest answer is that the clinical trial data does not give a clean number on this.
Muscle loss is another factor worth flagging. If calorie intake falls steeply without enough protein or resistance activity, some loss of lean mass is possible, and muscle is metabolically active tissue that contributes to warmth. This is one reason our prescribers often talk about protein adequacy and strength training alongside treatment.
Most of the time, a mild background chill on semaglutide is not alarming. But there are situations where a symptom like this warrants a proper assessment. Hypothyroidism, anaemia and poor circulation can all produce cold intolerance, and starting a new medicine does not rule them out. If the cold feeling is severe, accompanied by fatigue, hair loss, weight gain despite treatment, or very slow pulse, those are patterns a GP should evaluate. Similarly, if you feel cold alongside nausea severe enough to restrict fluid intake, dehydration becomes a concern — GI side effects from semaglutide can occasionally tip into that territory.
For context on what the usual side effect profile of Wegovy looks like in practice, the cold on Wegovy page goes into more detail. The broader question of whether Wegovy makes you feel cold and what the data supports is also addressed there. If you are ever uncertain about a symptom, the right move is to contact your prescribing service rather than wait. You can reach the nume team via the contact page, and the FAQs cover a number of common treatment questions.
Semaglutide in its weight-management form, Wegovy, is a prescription-only medicine licensed in the UK for adults with a BMI of 30 or above, or 27 and above with a weight-related health condition. It is not available without a clinical assessment, and that assessment exists precisely so that symptoms like this one get considered in the context of your full health picture. A clinician who knows your history can distinguish a treatment-related adjustment from something that needs separate investigation.
If you are thinking about cost alongside treatment decisions, the Wegovy cost context page explains what private prescriptions typically include and what the price variation in the UK market actually reflects. At nume, treatment is reviewed by a real prescriber before every repeat, not an automated system. If a cold feeling or any other new symptom comes up between orders, aftercare is available seven days a week. To discuss suitability and get a clinical assessment, you are welcome to speak to our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.